Xuezhikang capsule

DRUG2 trials

Sponsors

China Academy of Chinese Medical Sciences, Heart Health Research Center

Conditions

DyslipidemiaMetabolism Disorder, GlucoseMetabolism Disorder, Lipid

Phase 4

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

CompletedNCT02057302

China Academy of Chinese Medical SciencesDyslipidemia

Start: 2010-03-31Updated: 2014-02-07

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

CompletedNCT05238012

Heart Health Research CenterMetabolism Disorder, Glucose, Metabolism Disorder, Lipid

Start: 2022-08-02End: 2024-04-02Updated: 2024-05-21